Penumbra Inc
PEN231.540USD
-1.830-0.78%
Close 10/30, 16:00（ET）Quotes delayed by 15 min
9.02BMarket Cap
61.09P/E TTM
More Details of Penumbra Inc Company
Penumbra, Inc. is a healthcare company. The Company designs, develops, manufactures, and markets products and has a portfolio that addresses challenging medical conditions in markets with unmet need. It is focused on developing, manufacturing, and marketing products for use by specialist physicians and healthcare providers to drive improved clinical and health outcomes. It is focused on developing and building its portfolio of products, including its thrombectomy, embolization, access, and immersive healthcare technologies. Common conditions that the Company focuses on Pulmonary Embolism, Deep Vein Thrombosis, Peripheral Arterial Occlusion, Ischemic Stroke, Acute Coronary Syndrome, Clot associated with Arteriovenous Graft or Fistula, Aneurysm, and Hemorrhagic Stroke. The Company sells its products to healthcare providers primarily through its direct sales organization in the United States, Europe, Canada and Australia, as well as through distributors in select international markets.
Penumbra Inc Info
Ticker SymbolPEN
Company namePenumbra Inc
IPO dateSep 18, 2015
CEOMr. Adam Elsesser, J.D.
Number of employees4500
Security typeOrdinary Share
Fiscal year-endSep 18
AddressOne Penumbra Place
CityALAMEDA
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code94502
Phone15109952486
Websitehttps://www.penumbrainc.com/
Ticker SymbolPEN
IPO dateSep 18, 2015
CEOMr. Adam Elsesser, J.D.
Company Executives of Penumbra Inc
Name
Name/Position
Position
Shareholding
Change
Mr. Adam Elsesser, J.D.
Mr. Adam Elsesser, J.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.02M
+1.21%
Dr. Arani Bose, M.D.
Dr. Arani Bose, M.D.
Director
Director
290.26K
-3.97%
Ms. Johanna Roberts
Ms. Johanna Roberts
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
51.68K
-1.15%
Ms. Shruthi Narayan
Ms. Shruthi Narayan
President
President
26.96K
-4.58%
Mr. Lambert Shiu
Mr. Lambert Shiu
Chief Accounting Officer
Chief Accounting Officer
25.61K
-4.98%
Ms. Janet Leeds
Ms. Janet Leeds
Independent Director
Independent Director
5.49K
-1.06%
Ms. Bridget O'Rourke
Ms. Bridget O'Rourke
Independent Director
Independent Director
4.82K
-1.03%
Ms. Surbhi Sarna
Ms. Surbhi Sarna
Independent Director
Independent Director
3.15K
-1.84%
Ms. Maggie S. Yuen
Ms. Maggie S. Yuen
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Thomas C. (Tom) Wilder, III
Mr. Thomas C. (Tom) Wilder, III
Presiding Independent Director
Presiding Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Adam Elsesser, J.D.
Mr. Adam Elsesser, J.D.
Chairman of the Board, Chief Executive Officer
Chairman of the Board, Chief Executive Officer
1.02M
+1.21%
Dr. Arani Bose, M.D.
Dr. Arani Bose, M.D.
Director
Director
290.26K
-3.97%
Ms. Johanna Roberts
Ms. Johanna Roberts
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
51.68K
-1.15%
Ms. Shruthi Narayan
Ms. Shruthi Narayan
President
President
26.96K
-4.58%
Mr. Lambert Shiu
Mr. Lambert Shiu
Chief Accounting Officer
Chief Accounting Officer
25.61K
-4.98%
Ms. Janet Leeds
Ms. Janet Leeds
Independent Director
Independent Director
5.49K
-1.06%
Revenue Breakdown
Currency: USDUpdated: Mon, Oct 6
Currency: USDUpdated: Mon, Oct 6
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
By BusinessUSD
Name
Revenue
Proportion
Thrombectomy
230.26M
67.83%
Embolization and Access
109.20M
32.17%
By RegionUSD
Name
Revenue
Proportion
United States
260.82M
76.83%
International
78.64M
23.17%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Thrombectomy
230.26M
67.83%
Embolization and Access
109.20M
32.17%
Shareholding Stats
Updated: Wed, Oct 22
Updated: Wed, Oct 22
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
12.92%
The Vanguard Group, Inc.
9.88%
BlackRock Institutional Trust Company, N.A.
9.25%
T. Rowe Price Associates, Inc.
3.44%
State Street Investment Management (US)
3.00%
Other
61.51%
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
12.92%
The Vanguard Group, Inc.
9.88%
BlackRock Institutional Trust Company, N.A.
9.25%
T. Rowe Price Associates, Inc.
3.44%
State Street Investment Management (US)
3.00%
Other
61.51%
Shareholder Types
Shareholders
Proportion
Investment Advisor
60.23%
Investment Advisor/Hedge Fund
22.51%
Hedge Fund
5.08%
Individual Investor
3.73%
Pension Fund
1.88%
Research Firm
1.63%
Sovereign Wealth Fund
1.21%
Bank and Trust
0.52%
Private Equity
0.08%
Other
3.13%
Institutional Shareholding
Updated: Wed, Oct 1
Updated: Wed, Oct 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q3
844
36.41M
93.36%
-2.48M
2025Q2
864
37.32M
95.72%
-2.83M
2025Q1
878
36.92M
95.33%
-3.44M
2024Q4
834
37.02M
96.10%
-3.78M
2024Q3
813
37.33M
96.12%
-2.93M
2024Q2
796
37.57M
96.93%
+395.13K
2024Q1
777
35.67M
92.18%
-2.09M
2023Q4
759
36.33M
94.13%
-67.98K
2023Q3
737
35.15M
91.46%
-2.09M
2023Q2
719
36.20M
94.64%
-1.94M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Fidelity Management & Research Company LLC
5.04M
12.92%
+93.97K
+1.90%
Jun 30, 2025
The Vanguard Group, Inc.
3.85M
9.88%
+185.31K
+5.05%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
3.61M
9.25%
+78.78K
+2.23%
Jun 30, 2025
T. Rowe Price Associates, Inc.
1.34M
3.44%
+164.55K
+13.99%
Jun 30, 2025
State Street Investment Management (US)
1.17M
3%
-26.92K
-2.25%
Jun 30, 2025
Elsesser (Adam)
1.02M
2.62%
+12.18K
+1.21%
Sep 03, 2025
Baillie Gifford & Co.
922.13K
2.36%
+233.13K
+33.84%
Jun 30, 2025
RTW Investments L.P.
863.55K
2.21%
+783.00
+0.09%
Jun 30, 2025
Fidelity Institutional Asset Management
818.24K
2.1%
-76.68K
-8.57%
Jun 30, 2025
Champlain Investment Partners, LLC
743.71K
1.91%
-126.21K
-14.51%
Jun 30, 2025
View more
Related ETFs
Updated: Mon, Oct 6
Updated: Mon, Oct 6
Name
Proportion
Motley Fool Small-Cap Growth ETF
3.26%
Congress SMid Growth ETF
2.33%
SPDR S&P Health Care Equipment ETF
1.95%
First Trust Indxx Medical Devices ETF
1.84%
ROBO Global Healthcare Technology & Innovation ETF
1.71%
Invesco S&P MidCap Quality ETF
1.59%
Putnam Sustainable Future ETF
1.45%
iShares U.S. Medical Devices ETF
1.21%
First Trust Health Care Alphadex Fund
0.91%
Fidelity Women's Leadership ETF
0.78%
View more
Motley Fool Small-Cap Growth ETF
Proportion3.26%
Congress SMid Growth ETF
Proportion2.33%
SPDR S&P Health Care Equipment ETF
Proportion1.95%
First Trust Indxx Medical Devices ETF
Proportion1.84%
ROBO Global Healthcare Technology & Innovation ETF
Proportion1.71%
Invesco S&P MidCap Quality ETF
Proportion1.59%
Putnam Sustainable Future ETF
Proportion1.45%
iShares U.S. Medical Devices ETF
Proportion1.21%
First Trust Health Care Alphadex Fund
Proportion0.91%
Fidelity Women's Leadership ETF
Proportion0.78%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
